Search results
Results From The WOW.Com Content Network
Alkermes plc is a fully-integrated biopharmaceutical company that focuses on developing medicines for psychiatric and neurological disorders. The company was founded in 1987 by Michael Wall. [ 3 ] In September 2011 Alkermes, Inc. merged with Elan Drug Technologies (EDT), the former drug formulation and manufacturing division of Élan ...
It makes up essentially all Elan's sales after selling its drug- delivery technology to Alkermes. Tysabri comprises ... and Elan (NYS: ELN) . It makes up essentially all Elan's sales after selling ...
Elan was able to secure more cash through the sale of Elan Drug Technology to Alkermes (NAS: ALKS) this year. The biotech had previously tried to sell the unit that helps companies make extended ...
When I interviewed Alkermes' CEO Richard Pops last year, he described the relocation of the company's headquarters to Ireland where taxes are lower after buying Elan's drug technology business as ...
Bapineuzumab was being co-developed by the pharmaceutical companies Élan and Wyeth and entered Phase III trials in December 2007. [7] In 2008 a Johnson & Johnson affiliate acquired a substantial portion of Élan's assets related to the Alzheimer's immunotherapy program, which Elan had shared with Wyeth.
Alkermes plc is a fully-integrated biopharmaceutical company that focuses on developing medicines for psychiatric and neurological disorders. The company was founded in 1987 by Michael Wall. [3] In September 2011 Alkermes, Inc. merged with Elan Drug Technologies (EDT), the former drug formulation and manufacturing division of Élan Corporation ...
Elan Sells Its Remaining Stake in Alkermes DUBLIN--(BUSINESS WIRE)-- Elan Corporation, plc ("Elan") (NYS: ELN) announced that, following the close of trading today, Elan, through its wholly-owned ...
Perrigo Company plc (Hebrew: פריגו) is an American Irish -registered manufacturer of private label over-the-counter pharmaceuticals, and while 70% of Perrigo's net sales are from the U.S. healthcare system, Perrigo is legally headquartered in Ireland for tax purposes, which accounts for 0.60% of net sales. [2][3] In 2013, Perrigo completed ...